Table of Content

1 Chinese Patent Medicine Market Overview
1.1 Product Overview and Scope of Chinese Patent Medicine
1.2 Chinese Patent Medicine Segment by Type
1.2.1 Global Chinese Patent Medicine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Syrup
1.2.3 Liquid
1.2.4 Tablet
1.2.5 Others
1.3 Chinese Patent Medicine Segment by Application
1.3.1 Chinese Patent Medicine Sales Comparison by Application: (2021-2027)
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Global Chinese Patent Medicine Market Size Estimates and Forecasts
1.4.1 Global Chinese Patent Medicine Revenue 2016-2027
1.4.2 Global Chinese Patent Medicine Sales 2016-2027
1.4.3 Chinese Patent Medicine Market Size by Region: 2016 Versus 2021 Versus 2027

2 Chinese Patent Medicine Market Competition by Manufacturers
2.1 Global Chinese Patent Medicine Sales Market Share by Manufacturers (2016-2021)
2.2 Global Chinese Patent Medicine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Chinese Patent Medicine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Chinese Patent Medicine Manufacturing Sites, Area Served, Product Type
2.5 Chinese Patent Medicine Market Competitive Situation and Trends
2.5.1 Chinese Patent Medicine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Chinese Patent Medicine Players Market Share by Revenue
2.5.3 Global Chinese Patent Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Chinese Patent Medicine Retrospective Market Scenario by Region
3.1 Global Chinese Patent Medicine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Chinese Patent Medicine Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Chinese Patent Medicine Market Facts & Figures by Country
3.3.1 North America Chinese Patent Medicine Sales by Country
3.3.2 North America Chinese Patent Medicine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Chinese Patent Medicine Market Facts & Figures by Country
3.4.1 Europe Chinese Patent Medicine Sales by Country
3.4.2 Europe Chinese Patent Medicine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Chinese Patent Medicine Market Facts & Figures by Region
3.5.1 Asia Pacific Chinese Patent Medicine Sales by Region
3.5.2 Asia Pacific Chinese Patent Medicine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Chinese Patent Medicine Market Facts & Figures by Country
3.6.1 Latin America Chinese Patent Medicine Sales by Country
3.6.2 Latin America Chinese Patent Medicine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Chinese Patent Medicine Market Facts & Figures by Country
3.7.1 Middle East and Africa Chinese Patent Medicine Sales by Country
3.7.2 Middle East and Africa Chinese Patent Medicine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Chinese Patent Medicine Historic Market Analysis by Type
4.1 Global Chinese Patent Medicine Sales Market Share by Type (2016-2021)
4.2 Global Chinese Patent Medicine Revenue Market Share by Type (2016-2021)
4.3 Global Chinese Patent Medicine Price by Type (2016-2021)

5 Global Chinese Patent Medicine Historic Market Analysis by Application
5.1 Global Chinese Patent Medicine Sales Market Share by Application (2016-2021)
5.2 Global Chinese Patent Medicine Revenue Market Share by Application (2016-2021)
5.3 Global Chinese Patent Medicine Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Shanghai Pharmaceutical (Group) Co., Ltd.
6.1.1 Shanghai Pharmaceutical (Group) Co., Ltd. Corporation Information
6.1.2 Shanghai Pharmaceutical (Group) Co., Ltd. Description and Business Overview
6.1.3 Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Shanghai Pharmaceutical (Group) Co., Ltd. Product Portfolio
6.1.5 Shanghai Pharmaceutical (Group) Co., Ltd. Recent Developments/Updates
6.2 China Pharmaceutical Group Corporation
6.2.1 China Pharmaceutical Group Corporation Corporation Information
6.2.2 China Pharmaceutical Group Corporation Description and Business Overview
6.2.3 China Pharmaceutical Group Corporation Chinese Patent Medicine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 China Pharmaceutical Group Corporation Product Portfolio
6.2.5 China Pharmaceutical Group Corporation Recent Developments/Updates
6.3 Guangzhou Pharmaceutical Group Co., Ltd.
6.3.1 Guangzhou Pharmaceutical Group Co., Ltd. Corporation Information
6.3.2 Guangzhou Pharmaceutical Group Co., Ltd. Description and Business Overview
6.3.3 Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Guangzhou Pharmaceutical Group Co., Ltd. Product Portfolio
6.3.5 Guangzhou Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.4 Tianjin Pharmaceutical Group Co., Ltd.
6.4.1 Tianjin Pharmaceutical Group Co., Ltd. Corporation Information
6.4.2 Tianjin Pharmaceutical Group Co., Ltd. Description and Business Overview
6.4.3 Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Tianjin Pharmaceutical Group Co., Ltd. Product Portfolio
6.4.5 Tianjin Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.5 Harbin Pharmaceutical Group Co., Ltd
6.5.1 Harbin Pharmaceutical Group Co., Ltd Corporation Information
6.5.2 Harbin Pharmaceutical Group Co., Ltd Description and Business Overview
6.5.3 Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Harbin Pharmaceutical Group Co., Ltd Product Portfolio
6.5.5 Harbin Pharmaceutical Group Co., Ltd Recent Developments/Updates
6.6 Nanjing Pharmaceutical Industry (Group) Co., Ltd.
6.6.1 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Corporation Information
6.6.2 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Description and Business Overview
6.6.3 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Product Portfolio
6.6.5 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Recent Developments/Updates
6.7 North China Pharmaceutical Group Co., Ltd.
6.6.1 North China Pharmaceutical Group Co., Ltd. Corporation Information
6.6.2 North China Pharmaceutical Group Co., Ltd. Description and Business Overview
6.6.3 North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 North China Pharmaceutical Group Co., Ltd. Product Portfolio
6.7.5 North China Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.8 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd.
6.8.1 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Corporation Information
6.8.2 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Description and Business Overview
6.8.3 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Product Portfolio
6.8.5 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.9 Taiji Group Co., Ltd.
6.9.1 Taiji Group Co., Ltd. Corporation Information
6.9.2 Taiji Group Co., Ltd. Description and Business Overview
6.9.3 Taiji Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Taiji Group Co., Ltd. Product Portfolio
6.9.5 Taiji Group Co., Ltd. Recent Developments/Updates
6.10 Xinhualu Anti-Pharmaceutical Group Co., Ltd.
6.10.1 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Corporation Information
6.10.2 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Description and Business Overview
6.10.3 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Product Portfolio
6.10.5 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.11 Nanjing Pharmaceutical Co., Ltd
6.11.1 Nanjing Pharmaceutical Co., Ltd Corporation Information
6.11.2 Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Description and Business Overview
6.11.3 Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Nanjing Pharmaceutical Co., Ltd Product Portfolio
6.11.5 Nanjing Pharmaceutical Co., Ltd Recent Developments/Updates
6.12 Chongqing Pharmaceutical Co., Ltd
6.12.1 Chongqing Pharmaceutical Co., Ltd Corporation Information
6.12.2 Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Description and Business Overview
6.12.3 Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Chongqing Pharmaceutical Co., Ltd Product Portfolio
6.12.5 Chongqing Pharmaceutical Co., Ltd Recent Developments/Updates
6.13 Hangzhou Huadong Pharmaceutical Group Co., Ltd.
6.13.1 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Corporation Information
6.13.2 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Description and Business Overview
6.13.3 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Product Portfolio
6.13.5 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.14 Jiangxi Pharmaceutical Group Corporation
6.14.1 Jiangxi Pharmaceutical Group Corporation Corporation Information
6.14.2 Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Description and Business Overview
6.14.3 Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Jiangxi Pharmaceutical Group Corporation Product Portfolio
6.14.5 Jiangxi Pharmaceutical Group Corporation Recent Developments/Updates
6.15 Shijiazhuang Pharmaceutical Group Co., Ltd.
6.15.1 Shijiazhuang Pharmaceutical Group Co., Ltd. Corporation Information
6.15.2 Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Description and Business Overview
6.15.3 Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Shijiazhuang Pharmaceutical Group Co., Ltd. Product Portfolio
6.15.5 Shijiazhuang Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.16 Northeast Pharmaceutical Group Co., Ltd.
6.16.1 Northeast Pharmaceutical Group Co., Ltd. Corporation Information
6.16.2 Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Description and Business Overview
6.16.3 Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Northeast Pharmaceutical Group Co., Ltd. Product Portfolio
6.16.5 Northeast Pharmaceutical Group Co., Ltd. Recent Developments/Updates

7 Chinese Patent Medicine Manufacturing Cost Analysis
7.1 Chinese Patent Medicine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Chinese Patent Medicine
7.4 Chinese Patent Medicine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Chinese Patent Medicine Distributors List
8.3 Chinese Patent Medicine Customers

9 Chinese Patent Medicine Market Dynamics
9.1 Chinese Patent Medicine Industry Trends
9.2 Chinese Patent Medicine Growth Drivers
9.3 Chinese Patent Medicine Market Challenges
9.4 Chinese Patent Medicine Market Restraints

10 Global Market Forecast
10.1 Chinese Patent Medicine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Chinese Patent Medicine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Chinese Patent Medicine by Type (2022-2027)
10.2 Chinese Patent Medicine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Chinese Patent Medicine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Chinese Patent Medicine by Application (2022-2027)
10.3 Chinese Patent Medicine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Chinese Patent Medicine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Chinese Patent Medicine by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Chinese Patent Medicine Sales (K MT) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Chinese Patent Medicine Sales (K MT) Comparison by Application (2021-2027)
Table 3. Global Chinese Patent Medicine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Chinese Patent Medicine Covered in This Study
Table 5. Global Chinese Patent Medicine Sales (K MT) of Key Manufacturers (2016-2021)
Table 6. Global Chinese Patent Medicine Sales Share by Manufacturers (2016-2021)
Table 7. Global Chinese Patent Medicine Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Chinese Patent Medicine Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Chinese Patent Medicine Average Price (USD/MT) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Chinese Patent Medicine Manufacturing Sites and Area Served
Table 11. Manufacturers Chinese Patent Medicine Product Type
Table 12. Global Chinese Patent Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Chinese Patent Medicine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chinese Patent Medicine as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Chinese Patent Medicine Sales by Region (2016-2021) & (K MT)
Table 16. Global Chinese Patent Medicine Sales Market Share by Region (2016-2021)
Table 17. Global Chinese Patent Medicine Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Chinese Patent Medicine Sales by Country (2016-2021) & (K MT)
Table 19. North America Chinese Patent Medicine Sales Market Share by Country (2016-2021)
Table 20. North America Chinese Patent Medicine Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Chinese Patent Medicine Revenue Market Share by Country (2016-2021)
Table 22. Europe Chinese Patent Medicine Sales by Country (2016-2021) & (K MT)
Table 23. Europe Chinese Patent Medicine Sales Market Share by Country (2016-2021)
Table 24. Europe Chinese Patent Medicine Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Chinese Patent Medicine Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Chinese Patent Medicine Sales by Region (2016-2021) & (K MT)
Table 27. Asia Pacific Chinese Patent Medicine Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Chinese Patent Medicine Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Chinese Patent Medicine Revenue Market Share by Region (2016-2021)
Table 30. Latin America Chinese Patent Medicine Sales by Country (2016-2021) & (K MT)
Table 31. Latin America Chinese Patent Medicine Sales Market Share by Country (2016-2021)
Table 32. Latin America Chinese Patent Medicine Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Chinese Patent Medicine Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Chinese Patent Medicine Sales by Country (2016-2021) & (K MT)
Table 35. Middle East and Africa Chinese Patent Medicine Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Chinese Patent Medicine Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Chinese Patent Medicine Revenue Market Share by Country (2016-2021)
Table 38. Global Chinese Patent Medicine Sales (K MT) by Type (2016-2021)
Table 39. Global Chinese Patent Medicine Sales Market Share by Type (2016-2021)
Table 40. Global Chinese Patent Medicine Revenue (Million US$) by Type (2016-2021)
Table 41. Global Chinese Patent Medicine Revenue Share by Type (2016-2021)
Table 42. Global Chinese Patent Medicine Price (USD/MT) by Type (2016-2021)
Table 43. Global Chinese Patent Medicine Sales (K MT) by Application (2016-2021)
Table 44. Global Chinese Patent Medicine Sales Market Share by Application (2016-2021)
Table 45. Global Chinese Patent Medicine Revenue (Million US$) by Application (2016-2021)
Table 46. Global Chinese Patent Medicine Revenue Share by Application (2016-2021)
Table 47. Global Chinese Patent Medicine Price (USD/MT) by Application (2016-2021)
Table 48. Shanghai Pharmaceutical (Group) Co., Ltd. Corporation Information
Table 49. Shanghai Pharmaceutical (Group) Co., Ltd. Description and Business Overview
Table 50. Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 51. Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Product
Table 52. Shanghai Pharmaceutical (Group) Co., Ltd. Recent Developments/Updates
Table 53. China Pharmaceutical Group Corporation Corporation Information
Table 54. China Pharmaceutical Group Corporation Description and Business Overview
Table 55. China Pharmaceutical Group Corporation Chinese Patent Medicine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 56. China Pharmaceutical Group Corporation Chinese Patent Medicine Product
Table 57. China Pharmaceutical Group Corporation Recent Developments/Updates
Table 58. Guangzhou Pharmaceutical Group Co., Ltd. Corporation Information
Table 59. Guangzhou Pharmaceutical Group Co., Ltd. Description and Business Overview
Table 60. Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 61. Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product
Table 62. Guangzhou Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 63. Tianjin Pharmaceutical Group Co., Ltd. Corporation Information
Table 64. Tianjin Pharmaceutical Group Co., Ltd. Description and Business Overview
Table 65. Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 66. Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product
Table 67. Tianjin Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 68. Harbin Pharmaceutical Group Co., Ltd Corporation Information
Table 69. Harbin Pharmaceutical Group Co., Ltd Description and Business Overview
Table 70. Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 71. Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Product
Table 72. Harbin Pharmaceutical Group Co., Ltd Recent Developments/Updates
Table 73. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Corporation Information
Table 74. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Description and Business Overview
Table 75. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 76. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Product
Table 77. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Recent Developments/Updates
Table 78. North China Pharmaceutical Group Co., Ltd. Corporation Information
Table 79. North China Pharmaceutical Group Co., Ltd. Description and Business Overview
Table 80. North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 81. North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product
Table 82. North China Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 83. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Corporation Information
Table 84. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Description and Business Overview
Table 85. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 86. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product
Table 87. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 88. Taiji Group Co., Ltd. Corporation Information
Table 89. Taiji Group Co., Ltd. Description and Business Overview
Table 90. Taiji Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 91. Taiji Group Co., Ltd. Chinese Patent Medicine Product
Table 92. Taiji Group Co., Ltd. Recent Developments/Updates
Table 93. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Corporation Information
Table 94. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Description and Business Overview
Table 95. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 96. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product
Table 97. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 98. Nanjing Pharmaceutical Co., Ltd Corporation Information
Table 99. Nanjing Pharmaceutical Co., Ltd Description and Business Overview
Table 100. Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 101. Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Product
Table 102. Nanjing Pharmaceutical Co., Ltd Recent Developments/Updates
Table 103. Chongqing Pharmaceutical Co., Ltd Corporation Information
Table 104. Chongqing Pharmaceutical Co., Ltd Description and Business Overview
Table 105. Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 106. Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Product
Table 107. Chongqing Pharmaceutical Co., Ltd Recent Developments/Updates
Table 108. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Corporation Information
Table 109. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Description and Business Overview
Table 110. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 111. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product
Table 112. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 113. Jiangxi Pharmaceutical Group Corporation Corporation Information
Table 114. Jiangxi Pharmaceutical Group Corporation Description and Business Overview
Table 115. Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 116. Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Product
Table 117. Jiangxi Pharmaceutical Group Corporation Recent Developments/Updates
Table 118. Shijiazhuang Pharmaceutical Group Co., Ltd. Corporation Information
Table 119. Shijiazhuang Pharmaceutical Group Co., Ltd. Description and Business Overview
Table 120. Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 121. Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product
Table 122. Shijiazhuang Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 123. Northeast Pharmaceutical Group Co., Ltd. Corporation Information
Table 124. Northeast Pharmaceutical Group Co., Ltd. Description and Business Overview
Table 125. Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 126. Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product
Table 127. Northeast Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 128. Production Base and Market Concentration Rate of Raw Material
Table 129. Key Suppliers of Raw Materials
Table 130. Chinese Patent Medicine Distributors List
Table 131. Chinese Patent Medicine Customers List
Table 132. Chinese Patent Medicine Market Trends
Table 133. Chinese Patent Medicine Growth Drivers
Table 134. Chinese Patent Medicine Market Restraints
Table 135. Global Chinese Patent Medicine Sales Forecast by Type (2022-2027) & (K MT)
Table 136. Global Chinese Patent Medicine Sales Market Share Forecast by Type (2022-2027)
Table 137. Global Chinese Patent Medicine Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 138. Global Chinese Patent Medicine Revenue Market Share Forecast by Type (2022-2027)
Table 139. Global Chinese Patent Medicine Sales Forecast by Application (2022-2027) & (K MT)
Table 140. Global Chinese Patent Medicine Sales Market Share Forecast by Application (2022-2027)
Table 141. Global Chinese Patent Medicine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 142. Global Chinese Patent Medicine Revenue Market Share Forecast by Application (2022-2027)
Table 143. Global Chinese Patent Medicine Sales Forecast by Region (2022-2027) & (K MT)
Table 144. Global Chinese Patent Medicine Sales Market Share Forecast by Region (2022-2027)
Table 145. Global Chinese Patent Medicine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 146. Global Chinese Patent Medicine Revenue Market Share Forecast by Region (2022-2027)
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Chinese Patent Medicine
Figure 2. Global Chinese Patent Medicine Market Share by Type in 2020 & 2027
Figure 3. Syrup Product Picture
Figure 4. Liquid Product Picture
Figure 5. Tablet Product Picture
Figure 6. Others Product Picture
Figure 7. Global Chinese Patent Medicine Market Share by Application in 2020 & 2027
Figure 8. Online Sales
Figure 9. Offline Sales
Figure 10. Global Chinese Patent Medicine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Chinese Patent Medicine Market Size 2016-2027 (US$ Million)
Figure 12. Global Chinese Patent Medicine Sales 2016-2027 (K MT)
Figure 13. Global Chinese Patent Medicine Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Chinese Patent Medicine Sales Share by Manufacturers in 2020
Figure 15. Global Chinese Patent Medicine Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Chinese Patent Medicine Players: Market Share by Revenue in 2020
Figure 17. Chinese Patent Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Chinese Patent Medicine Sales Market Share by Region (2016-2021)
Figure 19. Global Chinese Patent Medicine Sales Market Share by Region in 2020
Figure 20. Global Chinese Patent Medicine Revenue Market Share by Region (2016-2021)
Figure 21. Global Chinese Patent Medicine Revenue Market Share by Region in 2020
Figure 22. U.S. Chinese Patent Medicine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Chinese Patent Medicine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Chinese Patent Medicine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Chinese Patent Medicine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Chinese Patent Medicine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Chinese Patent Medicine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Chinese Patent Medicine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Chinese Patent Medicine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Chinese Patent Medicine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Chinese Patent Medicine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Chinese Patent Medicine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Chinese Patent Medicine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Chinese Patent Medicine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Chinese Patent Medicine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Chinese Patent Medicine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Chinese Patent Medicine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines Chinese Patent Medicine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam Chinese Patent Medicine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Chinese Patent Medicine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Chinese Patent Medicine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Chinese Patent Medicine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Chinese Patent Medicine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Chinese Patent Medicine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. U.A.E Chinese Patent Medicine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Chinese Patent Medicine by Type (2016-2021)
Figure 47. Sales Market Share of Chinese Patent Medicine by Application (2016-2021)
Figure 48. Sales Market Share of Chinese Patent Medicine by Application in 2020
Figure 49. Revenue Share of Chinese Patent Medicine by Application (2016-2021)
Figure 50. Revenue Share of Chinese Patent Medicine by Application in 2020
Figure 51. Manufacturing Cost Structure of Chinese Patent Medicine
Figure 52. Manufacturing Process Analysis of Chinese Patent Medicine
Figure 53. Chinese Patent Medicine Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed